HealthcareServices

MicroRNA Global Forecast: Market to Scale Up to $3.32 Billion by 2030 at 15.6% CAGR

February 26, 2026March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the microrna market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the MicroRNA Market by the end of 2030?

The microrna market has experienced substantial expansion in recent times. Projections indicate it will increase from $1.57 billion in 2025 to $1.86 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 18.5%. Historically, this growth was driven by factors such as the rise in genomic research adoption, an increasing demand for biomarker discovery, the growth of pcr-based testing, the expansion of cancer research programs, and the rising use of ngs instruments.

The microrna market is poised for substantial growth in the upcoming years, with its size projected to reach $3.32 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.6%. This expansion during the forecast period is fueled by factors such as the increasing clinical applications of microrna diagnostics, the growing adoption of personalized medicine, progress in therapeutic microrna development, the broadening scope of infectious disease research, and enhanced investments in molecular assay technologies. Key trends anticipated in this period include the expansion of precision genomics, AI-driven microrna expression analysis, a rise in cloud-based sequencing data storage, increased automation in molecular diagnostics, and the integration of IoT into laboratory workflows.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15608&type=smp

What Drivers Are Shaping Future Opportunities In The MicroRNA Market?

The increasing prevalence of cancer is projected to fuel the expansion of the microRNA market in the coming years. Cancer is defined as an intricate illness characterized by unchecked cell division and proliferation, often leading to the formation of cancerous tumors capable of invading nearby tissues and metastasizing to distant parts of the body, thereby posing considerable health dangers. The surge in cancer incidents is attributable to multiple causes, including an aging populace, lifestyle choices like smoking and poor dietary habits, environmental pollutants, and enhanced screening methods resulting in earlier diagnoses. MicroRNA is utilized in conjunction with traditional cancer treatments to improve drug sensitivity and patient outcomes. Beyond therapeutic applications, miRNAs serve as crucial diagnostic and prognostic indicators, aiding in the classification of cancer types, prediction of disease progression, and monitoring of treatment efficacy. For instance, in May 2024, data from the National Cancer Institute, a US-based government agency, indicated that approximately 20 million new cases and 9.7 million cancer-related deaths were recorded annually in 2022, with projections estimating 15.3 million deaths and 29.9 million new cases per year by 2040. Therefore, the rising number of cancer cases is a significant catalyst for the growth of the microRNA market.

Which Segments Are Gaining Traction In The MicroRNA Market?

The microrna market covered in this report is segmented –

1) By Product: Instruments, Consumables

2) By Assay Type: Immunoassay, Next Generation Sequencing, MiRNA Arrays, Polymerase Chain Reaction (PCR) Based Arrays

3) By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Other Applications

4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Clinical Research Organizations

Subsegments:

1) By Instruments: Quantitative PCR Systems, Microarray Platforms, Next-Generation Sequencing (NGS) Systems, Real-Time PCR Instruments, Microrna Analyzers

2) By Consumables: MicroRNA Kits ( Extraction Kits, Detection Kits), PCR Reagents, Primers And Probes, Microarrays And Chips, RNA Sequencing Kits

What Industry Trends Are Transforming The MicroRNA Market?

Leading companies in the microRNA market are concentrating on developing advanced solutions, such as miRNA probe customization services, to fulfill the specific requirements of researchers and clinicians, improve the accuracy of miRNA detection, and support a broad spectrum of applications. MiRNA probe customization services involve specialized offerings from biotechnology and molecular biology firms for designing and producing probes tailored to specific microRNAs (miRNAs) for diverse research and clinical uses. For instance, in September 2023, Abnova Corporation, a Taiwan-based biotech company, launched enhanced services for customizing miRNA probes, along with a new range of cataloged miRNA probes, to meet the varied demands of academic, industrial, and research communities engaged in miRNA studies. These probes are crucial for identifying and precisely locating miRNAs, which are small, non-coding RNA molecules vital for various biological processes. Abnova’s customization services ensure high specificity and minimal cross-reactivity, making them particularly suitable for analyzing samples with limited miRNA content.

Who Are The Primary Competitors In The Global MicroRNA Market?

Major companies operating in the microrna market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., HTG Molecular Diagnostics Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/microrna-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The MicroRNA Market?

North America was the largest region in the microRNA market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the microrna market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized MicroRNA Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15608&type=smp

Browse Through More Reports Similar to the Global MicroRNA Market 2026, By The Business Research Company

Rna Analysis Transcriptomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

Microarray Market Report 2026

https://www.thebusinessresearchcompany.com/report/microarray-global-market-report

Rna Targeting Small Molecules Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/rna-targeting-small-molecules-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795